What is Bayer?
Bayer AG is a German-based pharmaceutical and life sciences company. The 150-year-old company was the first in the world to introduce the flagship healthcare product aspirin. Today, Bayer is a multinational producer and marketer of innovative products in four core segments: Pharmaceuticals, Consumer Health, Animal Health and Crop Science.
On its website, Bayer explains that its innovative products are contributing to finding solutions to some of the world’s major challenges. The company says it is improving quality of life for a growing population by focusing its R&D on preventing, alleviating and treating diseases. It is also helping to provide a reliable supply of food, feed and plant-based raw materials.
In 2017 Bayer had just under 100,000 employees around the world. In the same year, Bayer was ranked no.174 in the Fortune Global 500 list of the world’s largest companies. As of April 2018, Bayer AG had a market capitalisation of around €80 billion.
Who are the key people at Bayer?
Werner Baumann was appointed Chairman of the Board of Management (CEO) of Bayer AG in May 2016, and has been with the company since 1988. Another key figure is Johannes Dietsch, who is Chief Financial Officer and is also responsible for the regions Asia/Pacific and North America. Dieter Weinand is the President of Bayer Pharmaceuticals, and Heiko Schipper is President of the Consumer Health division.
What is the modern history of Bayer?
Bayer was founded in 1863, was part of chemicals giant IG Farben from 1925-52, and then returned to being an independent company. The new millennium saw the landmark acquisition of Schering in 2006 – the largest takeover in Bayer's history, and one of the biggest pharma mergers of all time. In September 2015 Bayer spun out its materials science division into a separate publicly traded company called Covestro, retaining about a 70% interest in the business.
What are the latest developments at Bayer?
In its full year 2017 financial results, Bayer reported group sales up 1.5% at €35.0 billion, and net income up 61.9% at €7.3 billion. Core earnings per share were €6.74 – up 1.0% on the previous year. It was another record year for the group’s Pharmaceuticals division, but there was weak business development at Consumer Health.
In April 2018, the U.S. Department of Justice approved Bayer’s bid to buy seed giant Monsanto for more than $60 billion. Bayer agreed to sell off additional assets to address anti-trust concerns. The deal had already been given the green light by the European Commission.
The Bayer share price saw a period of almost uninterrupted growth from June 2012, when it stood at €49, to April 2015, when it peaked at €145. The shares then fell back to €85 in May 2016 before recovering to over €100 in 2017. To find out how the shares are doing right now, follow Capital.com. Our BAYN chart puts all the information at your fingertips.
Where does Bayer operate?
The company is headquartered in Leverkusen, Germany, but has operations right around the world. In 2017 Bayer achieved sales of €13.4 billion in Europe, Middle East & Africa; sales of €7.6 billion in Asia/Pacific; sales of €10.1 billion in North America; and sales of €3.8 billion in Latin America.
Where is Bayer traded?
Bayer stocks are listed on the Frankfurt Stock Exchange and are constituents of the Euro Stoxx 50 stock market index. Check out Capital.com for the latest BAYN chart. We’ll keep you up to date and in the picture.